WT1 and Kaposi's sarcoma: This study advances our understanding of how KSHV and a host cellular protein, WT1, interact, possibly to promote tumorigenesis and importantly, to support the pre-clinical rationale for conducting anti-WT1 immunotherapy trials in KS.